Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Fallback Plan Would Be More Likely Under Sen. Kennedy Bill

Executive Summary

Government-sponsored Medicare prescription drug fallback plans would be more widely available under a bill introduced by Sen. Edward Kennedy (D-Mass.)

You may also be interested in...



Medicare Rx “Fallback” Plans Ensured Small Role Under CMS Rule

Entities administering a Medicare prescription drug "fallback" plan in a single U.S. region will be prohibited from bidding as stand-alone PDPs anywhere nationwide during the three-year contract term, CMS' proposed regulation says

Medicare Rx “Fallback” Plans Ensured Small Role Under CMS Rule

Entities administering a Medicare prescription drug "fallback" plan in a single U.S. region will be prohibited from bidding as stand-alone PDPs anywhere nationwide during the three-year contract term, CMS' proposed regulation says

Kerry/Edwards Medicare Rx “Overhaul” Plan: Negotiation, Not Dictation

Democratic presidential candidate John Kerry's plans to "overhaul" the Medicare Rx legislation would not involve direct price setting by the federal government, Kerry Campaign Policy Director Sarah Bianchi maintained during the Banc of America Washington Health Care Conference July 7

Related Content

UsernamePublicRestriction

Register

PS043219

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel